Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.76 - $4.64 $13,242 - $22,262
-4,798 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.87 - $9.16 $32,962 - $43,949
4,798 New
4,798 $40,000
Q4 2020

Feb 16, 2021

SELL
$12.07 - $17.95 $3.48 Million - $5.17 Million
-288,262 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$14.16 - $19.45 $4.08 Million - $5.61 Million
288,262 New
288,262 $4.75 Million

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.